Replies to post #299319 on Amarin Corp Plc (AMRN)

[MontanaState83]

If Thero had half the intellect of certain posters on this board (I ain't one) we might stand a chance.

[Jasbg]

JL@ Super post - and very well argued as always. Lets hope that Amarin management - is taking notice of the Raistimage idea/plan - that a number of others have actually brought forward as well.

And you took the plan 'All the Way' - as a possible 'full solution' to take Amarin - and the rest of us forward.

Raist and JL solution - Super Partnering with TEVA - have my vote !

Jasbg

PS. TEVA actually have a Danish very famous CEO Kaare Schultz

https://da.wikipedia.org/wiki/K%C3%A5re_Schultz (translate with google)

[Biobillionair]

JT needs to mention TEVA today and stop assuming generics have a "limited" supply. Additionally there is no mention of filing R-I infringement with any generic launch...this is unnerving. BB

https://amarincorp.gcs-web.com/static-files/ce00b635-f58a-4acd-9688-59b75039e24b

[ilovetech]

JL, I respectfully disagree. See my post: 299296

Teva solves supply side but not marketing. BP can crush supply side, and take V to parabolic sales highs. I don't see any need for selling at a discount. This business case is solid.

JMHO
ILT

[circuitcity]

Use the terminologies in oil and gas, a parter with teva will be like amrn doing upstream (api supply) and downstream (marketing both and brand sale) and teva doing midstream, aka distribution.

Same time, many including JT can keep their BP dream, continue to build pipeline, such as V 2.0, NASH, etc.

The best beauty of this business approach is the life goes well beyond 2029. It is not entirely impossible to recoup all the loss back or even more.

[HinduKush]

JL
Well said sir! I agree wholeheartedly. I wish the management would wake up from their hundred year slumber. We NEED a petition from ALL interested parties to make them somehow. Help Marjac/Raf/ILT/CBB/circuit/postes/anyone please. Thero could not organize a piss up in a brewery, let alone GIA. We will all be MIA.
HK